Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 513

Similar articles for PubMed (Select 15069073)

3.

Interaction of insulin-like growth factor II (IGF-II) with multiple plasma proteins: high affinity binding of plasminogen to IGF-II and IGF-binding protein-3.

Oesterreicher S, Blum WF, Schmidt B, Braulke T, K├╝bler B.

J Biol Chem. 2005 Mar 18;280(11):9994-10000. Epub 2005 Jan 10.

4.

The p53 oncoprotein is a substrate for tissue transglutaminase kinase activity.

Mishra S, Murphy LJ.

Biochem Biophys Res Commun. 2006 Jan 13;339(2):726-30. Epub 2005 Nov 28.

PMID:
16313886
5.
6.

Molecular characterization of covalent complexes between tissue transglutaminase and gliadin peptides.

Fleckenstein B, Qiao SW, Larsen MR, Jung G, Roepstorff P, Sollid LM.

J Biol Chem. 2004 Apr 23;279(17):17607-16. Epub 2004 Jan 27.

7.

Transglutaminase down-regulates the dimerization of epidermal growth factor receptor in rat perivenous and periportal hepatocytes.

Maruko A, Ohtake Y, Katoh S, Ohkubo Y.

Cell Prolif. 2009 Oct;42(5):647-56. doi: 10.1111/j.1365-2184.2009.00622.x. Epub 2009 Jul 9.

PMID:
19614676
8.

Characterization of insulin-like growth factor binding protein-1 kinases from human hepatoma cells.

Ankrapp DP, Jones JI, Clemmons DR.

J Cell Biochem. 1996 Mar 1;60(3):387-99.

PMID:
8867814
9.

Recent advances in understanding the roles of transglutaminase 2 in alcoholic steatohepatitis.

Tatsukawa H, Kojima S.

Cell Biol Int. 2010 Feb 22;34(3):325-34. doi: 10.1042/CBI20090130. Review.

PMID:
20192918
10.

Phosphorylation of transglutaminase 2 by PKA at Ser216 creates 14-3-3 binding sites.

Mishra S, Murphy LJ.

Biochem Biophys Res Commun. 2006 Sep 8;347(4):1166-70. Epub 2006 Jul 17.

PMID:
16870138
11.

Phosphorylation of histones by tissue transglutaminase.

Mishra S, Saleh A, Espino PS, Davie JR, Murphy LJ.

J Biol Chem. 2006 Mar 3;281(9):5532-8. Epub 2006 Jan 4.

13.

Mutation of a critical arginine in the GTP-binding site of transglutaminase 2 disinhibits intracellular cross-linking activity.

Begg GE, Holman SR, Stokes PH, Matthews JM, Graham RM, Iismaa SE.

J Biol Chem. 2006 May 5;281(18):12603-9. Epub 2006 Mar 7.

14.

Purification and characterization of rat brain transglutaminase.

Ohashi H, Itoh Y, Birckbichler PJ, Takeuchi Y.

J Biochem. 1995 Dec;118(6):1271-8.

15.

Role of transglutaminase 2 in liver injury via cross-linking and silencing of transcription factor Sp1.

Tatsukawa H, Fukaya Y, Frampton G, Martinez-Fuentes A, Suzuki K, Kuo TF, Nagatsuma K, Shimokado K, Okuno M, Wu J, Iismaa S, Matsuura T, Tsukamoto H, Zern MA, Graham RM, Kojima S.

Gastroenterology. 2009 May;136(5):1783-95.e10. doi: 10.1053/j.gastro.2009.01.007. Epub 2009 Jan 14.

PMID:
19208340
17.

Substrate preference of transglutaminase 2 revealed by logistic regression analysis and intrinsic disorder examination.

Csosz E, Bagossi P, Nagy Z, Dosztanyi Z, Simon I, Fesus L.

J Mol Biol. 2008 Nov 7;383(2):390-402. doi: 10.1016/j.jmb.2008.08.026. Epub 2008 Aug 22.

PMID:
18761350
19.

Role of N- and C-terminal residues of insulin-like growth factor (IGF)-binding protein-3 in regulating IGF complex formation and receptor activation.

Yan X, Forbes BE, McNeil KA, Baxter RC, Firth SM.

J Biol Chem. 2004 Dec 17;279(51):53232-40. Epub 2004 Oct 12.

20.

Insulin-like growth factor binding protein-3 is secreted as a phosphoprotein by human breast cancer cells.

Pattison ST, Fanayan S, Martin JL.

Mol Cell Endocrinol. 1999 Oct 25;156(1-2):131-9.

PMID:
10612431
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk